• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

包括肥胖在内的较大体型对原发性肾小球肾炎尿蛋白排泄量的影响:日本肾活检登记研究

The influences of larger physical constitutions including obesity on the amount of urine protein excretion in primary glomerulonephritis: research of the Japan Renal Biopsy Registry.

作者信息

Yonekura Yuriko, Goto Shunsuke, Sugiyama Hitoshi, Kitamura Hiroshi, Yokoyama Hitoshi, Nishi Shinichi

机构信息

Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, 2-5-1 Shikata, Okayama, 700-8558, Japan.

出版信息

Clin Exp Nephrol. 2015 Jun;19(3):359-70. doi: 10.1007/s10157-014-0993-y. Epub 2014 Jun 11.

DOI:10.1007/s10157-014-0993-y
PMID:24916004
Abstract

BACKGROUND

This study aimed to describe the influences of larger physical constitutions including obesity on the amount of urine protein excretion (AUPE) in primary glomerulonephritis. The distinct effects on the AUPE in various types of glomerulonephritis were evaluated.

METHODS

Using the database of the Japan Renal Biopsy Registry (J-RBR) from 2007 to 2010, 4060 cases with primary glomerulonephritis including MCNS, FSGS, MN, MPGN, IgAN, and non-IgA were reviewed. The AUPEs were compared between high and low Body Mass Index (BMI) groups, and larger and smaller body surface area (BSA) groups using the indexes of BMI 25.0 kg/m(2) and BSA 1.73 m(2) in all cases and in each histological group. Multivariable analysis was performed to evaluate the predominant contributors to the AUPE.

RESULTS

The larger physical constitution groups (BMI ≥25.0 kg/m(2) or BSA ≥1.73 m(2)) had significantly higher AUPEs in all cases with primary glomerulonephritis. When compared in each histological group, the mean AUPEs were significantly higher in the larger physical constitution groups, excluding the FSGS and non-IgA groups. Multiple regression analysis revealed that the significant contributors to the AUPE were BMI and BSA in MCNS and MN, whereas BMI and BSA were not significant and mean blood pressure and serum creatinine were significant in FSGS and non-IgA.

CONCLUSION

Larger physical constitutions including obesity had a significant impact on the increase in the AUPE in primary glomerulonephritis, especially in MCNS and MN. However, FSGS and non-IgA were distinct for having blood pressure and renal dysfunction as possibly the major causes of proteinuria.

摘要

背景

本研究旨在描述包括肥胖在内的较大体型对原发性肾小球肾炎患者尿蛋白排泄量(AUPE)的影响。评估了不同类型肾小球肾炎对AUPE的不同影响。

方法

使用日本肾活检登记处(J-RBR)2007年至2010年的数据库,回顾了4060例原发性肾小球肾炎患者,包括微小病变性肾病(MCNS)、局灶节段性肾小球硬化(FSGS)、膜性肾病(MN)、膜增生性肾小球肾炎(MPGN)、IgA肾病(IgAN)和非IgA肾病。在所有病例以及每个组织学组中,使用体重指数(BMI)25.0 kg/m²和体表面积(BSA)1.73 m²的指标,比较高BMI组和低BMI组以及大BSA组和小BSA组之间的AUPE。进行多变量分析以评估AUPE的主要影响因素。

结果

在所有原发性肾小球肾炎病例中,体型较大的组(BMI≥25.0 kg/m²或BSA≥1.73 m²)的AUPE显著更高。在每个组织学组中进行比较时,除FSGS组和非IgA肾病组外,体型较大的组的平均AUPE显著更高。多元回归分析显示,MCNS和MN中AUPE的显著影响因素是BMI和BSA,而在FSGS和非IgA肾病中,BMI和BSA不显著,平均血压和血清肌酐显著。

结论

包括肥胖在内的较大体型对原发性肾小球肾炎患者AUPE的增加有显著影响,尤其是在MCNS和MN中。然而,FSGS和非IgA肾病不同,血压和肾功能不全可能是蛋白尿的主要原因。

相似文献

1
The influences of larger physical constitutions including obesity on the amount of urine protein excretion in primary glomerulonephritis: research of the Japan Renal Biopsy Registry.包括肥胖在内的较大体型对原发性肾小球肾炎尿蛋白排泄量的影响:日本肾活检登记研究
Clin Exp Nephrol. 2015 Jun;19(3):359-70. doi: 10.1007/s10157-014-0993-y. Epub 2014 Jun 11.
2
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).日本老年原发性肾病综合征的结局:日本肾活检登记处(J-RBR)的回顾性分析。
Clin Exp Nephrol. 2015 Jun;19(3):496-505. doi: 10.1007/s10157-014-1022-x. Epub 2014 Sep 18.
3
Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.原发性肾小球肾炎中蛋白尿的特征:白蛋白尿聚合物
Am J Kidney Dis. 1997 Sep;30(3):404-12. doi: 10.1016/s0272-6386(97)90286-9.
4
Comparison of laboratory findings in patients with glomerulonephritis classified according to histopathologic diagnosis.根据病理组织学诊断对肾小球肾炎患者的实验室检查结果进行比较。
Minerva Med. 2014 Apr;105(2):149-56.
5
Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.系膜IgA肾小球肾炎和薄基底膜病患者的尿血小板因子4(Pf4)水平
Clin Nephrol. 1992 Jan;37(1):8-13.
6
Increasing incidence of focal segmental glomerulosclerosis and an examination of demographic patterns.局灶节段性肾小球硬化发病率的上升及人口统计学模式研究
Clin Nephrol. 2005 Jan;63(1):1-7. doi: 10.5414/cnp63001.
7
Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.日本肾病综合征生物标志物研究(J-MARINE)的原理和设计。
Clin Exp Nephrol. 2024 May;28(5):431-439. doi: 10.1007/s10157-023-02449-4. Epub 2024 Jan 25.
8
Spot urine protein/creatinine ratio as a reliable estimate of 24-hour proteinuria in patients with immunoglobulin A nephropathy, but not membranous nephropathy.尿蛋白/肌酐比值可准确估计 IgA 肾病患者的 24 小时尿蛋白,但不能准确估计膜性肾病患者的 24 小时尿蛋白。
BMC Nephrol. 2019 Aug 6;20(1):306. doi: 10.1186/s12882-019-1486-8.
9
A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.肾小球疾病中可溶性尿激酶型纤溶酶原激活物受体的重新评估
Kidney Int. 2015 Mar;87(3):564-74. doi: 10.1038/ki.2014.346. Epub 2014 Oct 29.
10
Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.尿N-乙酰-β-氨基葡萄糖苷酶排泄是肾小管细胞功能障碍的标志物,也是原发性肾小球肾炎预后的预测指标。
Nephrol Dial Transplant. 2002 Nov;17(11):1890-6. doi: 10.1093/ndt/17.11.1890.

引用本文的文献

1
Relationship of body mass index and kidney outcomes in patients with primary glomerulonephritis: A systematic review and meta-analysis.原发性肾小球肾炎患者体重指数与肾脏结局的关系:系统评价和荟萃分析。
Medicine (Baltimore). 2024 Oct 11;103(41):e39621. doi: 10.1097/MD.0000000000039621.
2
Association of Obesity With Kidney and Cardiac Outcomes Among Patients With Glomerular Disease: Findings From the Cure Glomerulonephropathy Network.肾小球疾病患者中肥胖与肾脏和心脏结局的关联:来自治愈肾小球肾病网络的研究结果
Am J Kidney Dis. 2024 Sep;84(3):306-319.e1. doi: 10.1053/j.ajkd.2024.03.020. Epub 2024 May 13.
3
Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies.

本文引用的文献

1
Pathophysiology and treatment of focal segmental glomerulosclerosis: the role of animal models.局灶节段性肾小球硬化症的病理生理学和治疗:动物模型的作用。
BMC Nephrol. 2013 Apr 1;14:74. doi: 10.1186/1471-2369-14-74.
2
Over- or underfill: not all nephrotic states are created equal.过填或欠填:并非所有肾病综合征都是相同的。
Pediatr Nephrol. 2013 Aug;28(8):1153-6. doi: 10.1007/s00467-013-2435-6. Epub 2013 Mar 26.
3
Direct and indirect effects of obesity on the kidney.肥胖对肾脏的直接和间接影响。
肥胖与原发性蛋白尿肾小球疾病的心血管危险因素和肾脏疾病结局的关系。
Nephron. 2021;145(3):245-255. doi: 10.1159/000513869. Epub 2021 Mar 5.
4
The revised version 2018 of the nationwide web-based registry system for kidney diseases in Japan: Japan Renal Biopsy Registry and Japan Kidney Disease Registry.日本全国性肾脏疾病在线注册系统的修订版 2018:日本肾脏活检注册和日本肾脏病注册。
Clin Exp Nephrol. 2020 Nov;24(11):1058-1068. doi: 10.1007/s10157-020-01932-6. Epub 2020 Aug 6.
5
Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases.肥胖与经活检证实的肾小球疾病患者进展为终末期肾病无关。
BMC Nephrol. 2019 Jul 2;20(1):237. doi: 10.1186/s12882-019-1434-7.
6
Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015.药物性肾病:一项对2007年至2015年日本肾活检登记处的研究。
Clin Exp Nephrol. 2016 Oct;20(5):720-730. doi: 10.1007/s10157-015-1201-4. Epub 2015 Nov 21.
Adv Chronic Kidney Dis. 2013 Mar;20(2):121-7. doi: 10.1053/j.ackd.2012.12.006.
4
Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010.日本肾活检登记处和日本肾脏病登记处:2009 年和 2010 年委员会报告。
Clin Exp Nephrol. 2013 Apr;17(2):155-73. doi: 10.1007/s10157-012-0746-8. Epub 2013 Feb 6.
5
Obesity and kidney disease: potential mechanisms.肥胖与肾脏疾病:潜在机制。
Semin Nephrol. 2013 Jan;33(1):14-22. doi: 10.1016/j.semnephrol.2012.12.006.
6
Improved renal function 12 months after bariatric surgery.体重减轻手术后 12 个月肾功能改善。
Surg Obes Relat Dis. 2013 Mar-Apr;9(2):202-6. doi: 10.1016/j.soard.2012.10.005. Epub 2012 Oct 26.
7
Associations of proteinuria, fluid volume imbalance, and body mass index with circadian ambulatory blood pressure in chronic kidney disease patients.蛋白尿、液体容量失衡和体重指数与慢性肾脏病患者的动态血压昼夜节律的相关性。
Kidney Blood Press Res. 2012;36(1):231-41. doi: 10.1159/000343412. Epub 2012 Nov 19.
8
The pathophysiology of edema formation in the nephrotic syndrome.肾病综合征水肿形成的病理生理学。
Kidney Int. 2012 Sep;82(6):635-42. doi: 10.1038/ki.2012.180. Epub 2012 Jun 20.
9
Inflammation and oxidative stress in obesity-related glomerulopathy.肥胖相关性肾小球病中的炎症与氧化应激
Int J Nephrol. 2012;2012:608397. doi: 10.1155/2012/608397. Epub 2012 Apr 5.
10
Weight loss improves renal hemodynamics in patients with metabolic syndrome.体重减轻可改善代谢综合征患者的肾血流动力学。
J Bras Nefrol. 2012 Mar;34(1):36-42.